MYLK Inhibitors
Santa Cruz Biotechnology now offers a broad range of MYLK Inhibitors. Myosin light chain kinases (MYLK, also designated MLCK) phosphorylate myosin regulatory light chains to catalyze myosin interaction with actin filaments resulting in contractile activity. MYLK members are known to include MYLK2, MYLK3 and MYLK4. MYLK Inhibitors offered by Santa Cruz inhibit MYLK and, in some cases, other serine/threonine and CaM kinase related proteins. View detailed MYLK Inhibitor specifications, including MYLK Inhibitor CAS number, molecular weight, molecular formula and chemical structure, by clicking on the product name.
SEE ALSO...
Items 31 to 32 of 32 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ellagic Acid, Dihydrate | 476-66-4 | sc-202598 sc-202598A sc-202598B sc-202598C | 500 mg 5 g 25 g 100 g | $57.00 $93.00 $240.00 $713.00 | 8 | |
Ellagic acid may decrease MYLK expression through its antioxidant properties, modulation of signaling pathways, and potential role in cellular stress response. | ||||||
Luteolin | 491-70-3 | sc-203119 sc-203119A sc-203119B sc-203119C sc-203119D | 5 mg 50 mg 500 mg 5 g 500 g | $26.00 $50.00 $99.00 $150.00 $1887.00 | 40 | |
Luteolin may inhibit MYLK expression through its anti-inflammatory properties, antioxidant effects, and modulation of signaling pathways. | ||||||